Asst. Prof. MUSTAFA DİKİLİTAŞ

Publication Network

Articles 19

1. Pretreatment Prognostic Nutritional Index Predicts Progression-Free Survival in BCLC Stage C Hepatocellular Carcinoma Treated with Sorafenib

AYDIN U., DİKİLİTAŞ M., BALIKÇI ÇİÇEK İ., Pamuk Ö. A., Sadak Öcal Z., DANACI Y., et al.

Cancer Management and Research , vol.18, 2026 (SCI-Expanded, Scopus)

2. PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

Wu Y., Wu L., Bi N., Cil T., Ge H., Zhu Z., et al.

Journal of Hematology and Oncology , vol.18, no.1, 2025 (SCI-Expanded, Scopus)

3. Liver Transplantation for Hepatocellular Carcinoma with Expanded Criteria: Malatya Experience

İNCE V., USTA S., CARR B. I., KUTLU R., DİKİLİTAŞ M., HARPUTLUOĞLU M. M. M., et al.

Journal of Inonu Liver Transplantation Institute , vol.2, no.2, pp.72-77, 2024 (Peer-Reviewed Journal)

4. Clinicopathological Features of Young Gastric Cancer and New Inflammatory Prognostic Markers

gülmez a., DİKİLİTAŞ M.

ACTA ONCOLOGICA TURCICA , vol.56, no.2, pp.90-96, 2023 (TRDizin)

5. Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better?

DİKİLİTAŞ M.

JOURNAL OF GASTROINTESTINAL CANCER , vol.51, no.4, pp.1193-1196, 2020 (ESCI, Scopus)

6. A rare case Of gastric cancer: Isolated vaginal metastasis

Gulmez A., DİKİLİTAŞ M.

CURRENT PROBLEMS IN CANCER , vol.44, no.5, 2020 (SCI-Expanded, Scopus) Sustainable Development

7. Liver Transplantation for Hepatocellular Carcinoma: Malatya Experience and Proposals for Expanded Criteria.

Ince V., Akbulut A. S., Otan E., Ersan V., Karakas S., Sahin T. T., et al.

Journal of gastrointestinal cancer , vol.51, no.3, pp.998-1005, 2020 (ESCI, Scopus)

8. Intestinal perforation after regorafenib usage

Sarici B., KARAKAŞ S., Uylas U., AKTAŞ A., Dikilitas M., KAYAALP C.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.2, pp.245-246, 2018 (SCI-Expanded, Scopus, TRDizin)

9. Stomach metastasis of malignant melanoma

BİLGİÇ Y., HARPUTLUOĞLU M. M. M., CAGIN Y. F., DİKİLİTAŞ M., AKATLI A. N., MEHRELİYEV e., et al.

annals of medical resaarch , 2018 (Peer-Reviewed Journal)

10. POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA

Kaplan N. B., HARPUTLUOĞLU H., Dikilitas M., ELKIRAN E. T., TEMELLİ Ö.

ACTA MEDICA MEDITERRANEA , vol.34, no.1, pp.39-42, 2018 (SCI-Expanded, Scopus) Sustainable Development

11. Prophylactic cranial irradiation in small cell lung cancer: A single-center experience.

TEMELLİ Ö., Bozdag N. K., Eraslan F. A., Gulbas H., GÜROCAK Ş., Dikilitas M.

BIOMEDICAL RESEARCH-INDIA , vol.28, no.16, pp.7122-7126, 2017 (SCI-Expanded, Scopus) Sustainable Development

12. Small Cell Neuroendocrine Tumor of the Larynx: Two Case Reports

TEMELLİ Ö., Bozdag N. K., Akatli A., Yaslikaya S., Dikilitas M.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.32, no.3, pp.116-119, 2017 (ESCI, Scopus, TRDizin) Sustainable Development

13. Survival and prognostic factors in patients with brain metastasis: Single center experience

Ekici K., TEMELLİ Ö., Dikilitas M., Dursun I. H., Kaplan N. B., KEKİLLİ E.

JOURNAL OF BUON , vol.21, no.4, pp.958-963, 2016 (SCI-Expanded, Scopus)

14. Factors Affecting Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis

HARPUTLUOĞLU H., Kaplan N., Dikilitas M., Yagar Y.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.4, pp.199-205, 2016 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

15. A rare granular cell tumor of the vulva: a case report

Bozdag Kaplan N., Dursun I. H., Dikilitas M., HARPUTLUOĞLU H., YILMAZ E., Sahin N.

TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.30, no.2, pp.78-81, 2015 (ESCI, Scopus)

16. Effects of cyanocobalamin on immunity in patients with pernicious anemia

ERKURT M. A., AYDOGDU I., Dikilitas M., KUKU İ., KAYA E., BAYRAKTAR N., et al.

MEDICAL PRINCIPLES AND PRACTICE , vol.17, no.2, pp.131-135, 2008 (SCI-Expanded, Scopus)

17. Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy

Baydar M., Dikilitas M., Sevinc A., Aydogdu I.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.97, no.8, pp.1161-1164, 2005 (SCI-Expanded, Scopus)

18. Hiperlökositozlu lösemi hastalarımızda terapötik ve proflaktik lökoferez Deneyimlerimiz

KUKU İ., KAYA E., ERKURT M. A., UZER E., ÖZGÜL M., DİKİLİTAŞ M., et al.

Turgut Özal Tıp Merkezi Dergisi , vol.11, no.4, pp.243-246, 2004 (Peer-Reviewed Journal)

19. Malatya ve Çevresi ABO ve Rh Kan Grubu Dağılımı

KUKU İ., KAYA E., ERKURT M. A., DİKİLİTAŞ M., YILDIZ R., ORHAN M., et al.

Turgut Özal Tıp Merkezi Dergisi , vol.11, no.4, pp.213-215, 2004 (Peer-Reviewed Journal) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 6

4. TANI ANINDA HİPERLÖKOSİTOZUN EŞLİK ETTİĞİ AKUT MİYELOBLASTİK LÖSEMİLİ HASTALARIMIZIN KLİNİK ÖZELLİKLERİ VE PROGNOZLARI

KAYA E., KUKU İ., AYDOĞDU İ., ULU R., ERKURT M. A., ATEŞ F., et al.

TÜRK HEMATOLOJİ DERNEĞİ 29. ULUSAL KONGRESİ, Turkey, 25 - 28 October 2002, (Full Text)

5. İdyopatik Trombositopenik Purpurada oral yüksek doz steroid tedavisi sonuçlarımız

Kuku I., Aydogdu I., KAYA E., Baydar M., DİKİLİTAŞ M., Ates F., et al.

XXIX. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 October 2002, pp.135, (Summary Text)

6. Tanı anında hiperlökositozun eşlik ettiği lösemili hastalarımızın klinik özellikleri ve prognozları

KAYA E., Kuku I., Aydogdu I., ULU R., ERKURT M. A., Ates F., et al.

XXIX. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 October 2002, pp.228, (Summary Text)

Books 1

1. KLİNİK HEMATOLOJİ ONKOLOJİ ATLASI

AYDOGDU İ., KAYA E., KUKU İ., ATEŞ F., ULU R., BAYDAR M., et al.

Sistem Sistem Ofset Basım Yayım, Ankara, 2004

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

163

H-Index (Scopus)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING

Publications & Works